Summary: My initial rating of Abbott Laboratories is a buy, agreeing with today’s Wall Street
Abbott Laboratories (NYSE:ABT) declares $0.59/share quarterly dividend, 7.3% increase from prior dividend of $0.55. Forward
LPETTET/iStock Unreleased via Getty Images A judge denied a request by Abbott Laboratories (NYSE:ABT) for
Summary: Abbott has a very stable gross profit margin, while the company’s revenue and return
JUN LI Canada has reported the first mpox case linked to the Clade I variant
baona/iStock via Getty Images Nearly three-quarters of institutional investors expect the MSCI World Health Care
Michail_Petrov-96/iStock via Getty Images Insulet (NASDAQ:PODD) said its Omnipod 5 automated insulin delivery system is
JUN LI/iStock via Getty Images California health officials have confirmed the first U.S. mpox case
LeoPatrizi Bernstein launched the coverage of insulin pump makers Tandem Diabetes Care (NASDAQ:TNDM) and Insulet
LPETTET Abbott (NYSE:ABT) shares are up ~5% in premarket trading Friday after a Missouri jury